Author Correction: A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention.
作者信息
Han Ahram, Lee Taeseung, Lee Joongyub, Song Suk-Won, Lee Sang-Su, Jung In Mok, Kang Jin Mo, Gwon Jun Gyo, Yun Woo-Sung, Cho Yong-Pil, Ko Hyunmin, Park Yang-Jin, Min Seung-Kee
机构信息
Division of Vascular Surgery, Department of Surgery, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
Seoul National University College of Medicine, Seoul, South Korea.
出版信息
Sci Rep. 2024 Aug 6;14(1):18234. doi: 10.1038/s41598-024-66740-4.
Abstract
摘要
相似文献
1
Author Correction: A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention.作者更正：股腘动脉介入术后缓释沙格雷酯与氯吡格雷的多中心、随机、开放标签、非劣效性试验。
Sci Rep. 2024 Aug 6;14(1):18234. doi: 10.1038/s41598-024-66740-4.
2
A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention.多中心、随机、开放标签、非劣效性试验：股浅动脉介入治疗后缓释沙格雷酯与氯吡格雷的比较。
Sci Rep. 2023 Feb 13;13(1):2502. doi: 10.1038/s41598-023-29006-z.
3
SAFE (Sarpogrelate Anplone in Femoro-popliteal artery intervention Efficacy) study: study protocol for a randomized controlled trial.SAFE（沙格雷酯在股腘动脉介入治疗中的疗效）研究：一项随机对照试验的研究方案。
Trials. 2017 Sep 22;18(1):439. doi: 10.1186/s13063-017-2155-5.
4
Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results.沙格雷酯与基于氯吡格雷的双重抗血小板治疗在股腘动脉血管内介入治疗患者中的前瞻性随机研究：初步结果
Chin Med J (Engl). 2015 Jun 20;128(12):1563-6. doi: 10.4103/0366-6999.158285.
5
Effectiveness of sarpogrelate after endovascular treatment for femoropopliteal artery disease: ESPALIER study.沙格雷酯用于股腘动脉疾病血管内治疗后的疗效：ESPALIER研究
Cardiovasc Interv Ther. 2017 Oct;32(4):325-332. doi: 10.1007/s12928-016-0414-0. Epub 2016 Jul 25.
6
Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.两种不同的自膨式镍钛合金支架治疗下肢动脉硬化闭塞症的疗效（SENS-FP试验）：一项随机对照试验的研究方案
Trials. 2014 Sep 10;15:355. doi: 10.1186/1745-6215-15-355.
7
Study design of the influence of SErotonin inhibition on patients with RENAl impairment or diabetes undergoing drug-eluting stent implantation (SERENADE) study: A multicenter, open-label, prospective, randomized study.血清素抑制对接受药物洗脱支架植入术的肾功能损害或糖尿病患者影响的研究（SERENADE）研究设计：一项多中心、开放标签、前瞻性、随机研究。
Contemp Clin Trials. 2015 Jul;43:20-4. doi: 10.1016/j.cct.2015.04.005. Epub 2015 Apr 16.
8
Ticagrelor versus clopidogrel in patients undergoing implantation of paclitaxel-eluting stent in the femoropopliteal district: A randomized pilot study using frequency-domain optical coherence tomography.替格瑞洛与氯吡格雷用于股腘动脉紫杉醇洗脱支架植入患者的比较：一项使用频域光学相干断层扫描的随机试验研究
Int J Cardiol. 2020 Apr 1;304:192-197. doi: 10.1016/j.ijcard.2020.01.024. Epub 2020 Jan 15.
9
A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial.聚合物涂层紫杉醇洗脱支架（Eluvia）与无聚合物紫杉醇涂层支架（Zilver PTX）治疗下肢股腘动脉腔内介入治疗（IMPERIAL）：一项随机非劣效试验。
Lancet. 2018 Oct 27;392(10157):1541-1551. doi: 10.1016/S0140-6736(18)32262-1. Epub 2018 Sep 24.
10
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.紫杉醇洗脱支架治疗股腘动脉的持久临床疗效：Zilver PTX随机试验的5年结果
Circulation. 2016 Apr 12;133(15):1472-83; discussion 1483. doi: 10.1161/CIRCULATIONAHA.115.016900. Epub 2016 Mar 11.
引用本文的文献
1
The effect of sarpogrelate compared to aspirin in high- or very-high-risk diabetes for primary prevention.沙格雷酯与阿司匹林相比对高危或极高危糖尿病患者一级预防的效果。
Sci Rep. 2025 Jan 29;15(1):3616. doi: 10.1038/s41598-025-87868-x.
Zotero 插件